1 completed, 1 not yet recruiting, 1 unknown. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Not yet recruiting 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow PET-MRI: new trials by email Literature Review of PET-MRI trials Research Report on PET-MRI
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Positron Emission Tomography (PET) Imaging of Chemotherapy-Induced Cardiotoxicity 68Ga-Galmydar, PET/MRI, 18F-FDG - Lymphoma Cancer, Breast Cancer | Phase 1 | Not yet recruiting | Washington University School of Medicine | 36 | 2026-11-01 | 2026-09-24 |
| [18F]-Fludarabine PET/MRI in Primary Central Nervous System Lymphoma PET-MRI - Primary Central Nervous System Lymphoma | Phase 1 | Completed | Assistance Publique - Hôpitaux de Paris | 10 | 2023-12-18 | 2025-08-22 |
| PET-CT/MRI in the Radiotherapy for Prostate Cancer PET-CT, PET-MRI - Prostate Cancer | Phase 1 / Phase 2 | Unknown | Xuzhou Medical University | 90 | 2016-09-01 | 2016-06-29 |
Breast Neoplasms (1) · Cardiotoxicity (1) · Cardiovascular Diseases (1) · Hodgkin Disease (1) · Lymphoma, Non-Hodgkin (1) · Prostatic Neoplasms (1)
Assistance Publique - Hôpitaux de Paris (1) · Washington University School of Medicine (1) · Xuzhou Medical University (1)
France (1) · United States (1)
Longzhen Zhang, MD (1) · Pamela K Woodard, MD (1)
R01HL180913 (1)